Cleared Traditional

K092593 - PROVOX ACTIVALVE (SIZE 4.5MM, 6MM, 8MM, 10MM, 12.5MM)

K092593 is an FDA 510(k) clearance for PROVOX ACTIVALVE (SIZE 4.5MM, manufactured by Atos Medical AB. The device is a Class 2 Ear, Nose, Throat device with product code EWL cleared through the Traditional 510(k) pathway after a 416-day FDA review.

K092593 · Atos Medical AB · Ear, Nose, Throat device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2010
Decision
416d
Days
Class 2
Risk

K092593 is an FDA 510(k) clearance for the PROVOX ACTIVALVE (SIZE 4.5MM, 6MM, 8MM, 10MM, 12.5MM). Classified as Prosthesis, Laryngeal (taub) (product code EWL), Class II - Special Controls.

Submitted by Atos Medical AB (Horby, SE). The FDA issued a Cleared decision on October 14, 2010 after a review of 416 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 874.3730 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Ear, Nose, Throat submissions.

FDA 510(k) Submission Details - K092593

510(k) Number K092593 FDA.gov
FDA Decision Cleared Substantially Equivalent - Special 510(k) (SESK)
Date Received August 24, 2009
Decision Date October 14, 2010
Days to Decision 416 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
326d slower than avg
Panel avg: 90d · This submission: 416d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

EWL Device Classification - Class 2, Special Controls

Product Code EWL Prosthesis, Laryngeal (taub)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 874.3730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ear, Nose, Throat devices follow this clearance model.

Regulatory Peers - EWL Prosthesis, Laryngeal (taub)

All 33
Devices cleared under the same product code (EWL) and FDA review panel - the closest regulatory comparables to K092593.
FirstFit Surgical Kit
K240763 · Freudenberg Medical, LLC · Dec 2024
PROVOX FREEHANDS FLEXIVOICE
K141380 · Atos Medical AB · Sep 2014
PROVOX VEGA PUNCTURE SET
K131947 · Atos Medical AB · Oct 2013
BLOM-SINGER INDWELLING TEP OCCLUDER
K093258 · Helix Medical, LLC · Mar 2010
PROVOX VEGA, MODEL 8130-8135
K090455 · Atos Medical AB · Jun 2009
BLOM-SINGER DUAL VALVE INDWELLING VOICE PROSTHESIS, MODELS DV-1600 SERIES, DV-2000 SERIES
K082206 · Helix Medical, LLC · Sep 2008